Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724).
Houchens, D P
Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724). [electronic resource] - Cancer chemotherapy reports - 967-73 p. digital
Publication Type: Journal Article
0069-0112
Animals
Antibody Formation--drug effects
Cyclophosphamide--analogs & derivatives
DNA, Neoplasm--biosynthesis
Female
Graft Rejection
Idoxuridine--metabolism
Ifosfamide--pharmacology
Immunosuppressive Agents
Liver--metabolism
Lung--metabolism
Lymphoma--immunology
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Inbred DBA
Mice, Inbred Strains
Neoplasm Transplantation
Radiation Effects
Spleen--metabolism
Transplantation, Homologous
Inhibition of antilymphoma allograft response in normal and lethally irradiated mice by cyclophosphamide (NSC-26271) and isophosphamide (NSC-109724). [electronic resource] - Cancer chemotherapy reports - 967-73 p. digital
Publication Type: Journal Article
0069-0112
Animals
Antibody Formation--drug effects
Cyclophosphamide--analogs & derivatives
DNA, Neoplasm--biosynthesis
Female
Graft Rejection
Idoxuridine--metabolism
Ifosfamide--pharmacology
Immunosuppressive Agents
Liver--metabolism
Lung--metabolism
Lymphoma--immunology
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Inbred DBA
Mice, Inbred Strains
Neoplasm Transplantation
Radiation Effects
Spleen--metabolism
Transplantation, Homologous